Lawrence E. Broder

1.7k total citations
28 papers, 1.3k citations indexed

About

Lawrence E. Broder is a scholar working on Oncology, Epidemiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Lawrence E. Broder has authored 28 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 10 papers in Epidemiology and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Lawrence E. Broder's work include Neuroendocrine Tumor Research Advances (9 papers), Lung Cancer Research Studies (9 papers) and Lung Cancer Treatments and Mutations (4 papers). Lawrence E. Broder is often cited by papers focused on Neuroendocrine Tumor Research Advances (9 papers), Lung Cancer Research Studies (9 papers) and Lung Cancer Treatments and Mutations (4 papers). Lawrence E. Broder collaborates with scholars based in United States, Ukraine and France. Lawrence E. Broder's co-authors include Martin H. Cohen, Oleg S. Selawry, Thomas H. Maren, Stephen K. Carter, John D. Minna, Byron E. Fossieck, Frank M. Schabel, Thomas P. Johnston, Douglass C. Tormey and Coralie Williams and has published in prestigious journals such as Annals of Internal Medicine, JNCI Journal of the National Cancer Institute and Cancer.

In The Last Decade

Lawrence E. Broder

28 papers receiving 1.1k citations

Peers

Countries citing papers authored by Lawrence E. Broder

Since Specialization

Citations

This map shows the geographic impact of Lawrence E. Broder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lawrence E. Broder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lawrence E. Broder more than expected).

Fields of papers citing papers by Lawrence E. Broder

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lawrence E. Broder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lawrence E. Broder. The network helps show where Lawrence E. Broder may publish in the future.

Co-authorship network of co-authors of Lawrence E. Broder

This figure shows the co-authorship network connecting the top 25 collaborators of Lawrence E. Broder. A scholar is included among the top collaborators of Lawrence E. Broder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lawrence E. Broder. Lawrence E. Broder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Chemotherapy of Brain Tumors 2015 ·Progress in tumor research ·Lawrence E. Broder, David P. Rall	2
2	A Randomized Clinical Trial in Bronchogenic Small-Cell Carcinoma Evaluating Alternating Maintenance Therapy of Vincristine, Adriamycin, Procarbazine, and Etoposide (VAPE) with Cyclophosphamide, CCNU, and Methotrexate (CCM) versus CCM Maintenance Alone in Complete Responders Following VAPE Induction and Late Intensification 1994 ·American Journal of Clinical Oncology ·Lawrence E. Broder, Kasi S. Sridhar, Oleg S. Selawry, (unknown), (unknown), Mario J. Saldana, (unknown), William A. Raub	8
3	Guanazole in the treatment of advanced bronchogenic carcinoma: a pilot study of the Southeastern Cancer Study Group. 1986 ·PubMed ·S Krauß, Lawrence E. Broder, Robert Birch	3
4	Lobular carcinoma of the breast metastatic to bone with unusual clinical, radiologic, and pathologic features mimicking osteopoikilosis 1984 ·Cancer ·Latifa Ghandur‐Mnaymneh, Lawrence E. Broder, Walid Mnaymneh	8
5	Experimental studies of the biology of human small cell lung cancer. 1983 ·PubMed ·D. N. Carney, Lawrence E. Broder, Michael Edelstein, Adi F. Gazdar, Mark Berner Hansen, K. Havemann, Mary J. Matthews, George D. Sorenson, (unknown)	52
6	Calcitonin as a marker for bronchogenic cancer.A prospective study 1979 ·Cancer ·Omega L. Silva, Lawrence E. Broder, John L. Doppman, Richard H. Snider, Charles F. Moore, Martin H. Cohen, Kenneth L. Becker	39
7	Bleomycin, methotrexate, and streptozotocin in epidermoid carcinoma of the lung: an active drug combination with major nonhematologic toxicity. 1978 ·Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·Daniel C. Ihde, Martin H. Cohen, Paul A. Bunn, Albert M. Bernath, Lawrence E. Broder, John D. Minna	2
8	Influence of Chemotherapeutic Agents on Chorionic Gonadotropin-Alpha Subunit Secretion in a Human Lung Cancer Cell Line (ChaGo): Discordance of Cytotoxic and Secretory Effects<xref ref-type="fn" rid="FN2">2</xref> 1978 ·JNCI Journal of the National Cancer Institute ·Lawrence E. Broder, Bruce D. Weintraub, Saul W. Rosen	5
9	Vitamin a serum levels and dietary vitamin a intake in lung cancer patients 1978 ·Cancer Letters ·Martin H. Cohen, Aron Primack, Lawrence E. Broder, (unknown)	15
10	Treatment of bronchogenic carcinoma 1977 ·Cancer Treatment Reviews ·Lawrence E. Broder, Martin H. Cohen, Oleg S. Selawry	88
11	Intensive chemotherapy of small cell bronchogenic carcinoma. 1977 ·PubMed ·Martin H. Cohen, Patrick J. Creaven, Byron E. Fossieck, Lawrence E. Broder, Oleg S. Selawry, (unknown), Coralie Williams, John D. Minna	212
12	Combination chemotherapy with vincristine, adriamycin, and procarbazine in previously treated patients with small cell carcinoma. 1977 ·PubMed ·Martin H. Cohen, Lawrence E. Broder, Byron E. Fossieck, Malcolm I. Bull, Daniel C. Ihde, John D. Minna	14
13	Placental proteins and their subunits as tumor markers in prostatic carcinoma 1977 ·Cancer ·Lawrence E. Broder, Bruce D. Weintraub, Saul W. Rosen, Martin H. Cohen, Francisco Tejada Cifuentes	17
14	Phase II clinical trial of weekly administration of VP-16-213 in small cell bronchogenic carcinoma. 1977 ·PubMed ·Martin H. Cohen, Lawrence E. Broder, Byron E. Fossieck, Daniel C. Ihde, John D. Minna	40
15	The Cytostatic Therapy of Hormone Secreting Tumours of the GI Tract 1974 ·Clinics in Gastroenterology ·Stephen K. Carter, Lawrence E. Broder	4
16	Pancreatic Islet Cell Carcinoma 1973 ·Annals of Internal Medicine ·Lawrence E. Broder, (unknown)	252
17	Pancreatic Islet Cell Carcinoma 1973 ·Annals of Internal Medicine ·Lawrence E. Broder, (unknown)	103
18	1,3-Bis(2-Chloroethyl)-1-Nitrosourea (Bcnu) And Other Nitrosoureas In Cancer Treatment: A Review 1973 ·Advances in cancer research ·Stephen K. Carter, Frank M. Schabel, Lawrence E. Broder, Thomas P. Johnston	143
19	THE ROLE OF CARBONIC ANHYDRASE IN ANION SECRETION INTO CEREBROSPINAL FLUID 1970 ·Journal of Pharmacology and Experimental Therapeutics ·Thomas H. Maren, Lawrence E. Broder	41
20	The excretion of drugs across the gill of the dogfish, Squalus acanthias 1968 ·Comparative Biochemistry and Physiology ·Thomas H. Maren, (unknown), Lawrence E. Broder	56

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact